TB-500 Therapy
What is TB-500?
TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide present in virtually all human and animal cells. It plays a crucial role in tissue repair, cell migration, and the formation of new blood vessels. TB-500 is widely studied for its ability to promote healing across multiple tissue types, including muscle, tendon, ligament, skin, heart, and eye tissue.
Benefits & Uses
Promotes tissue repair and regeneration, reduces inflammation and scar tissue formation, increases flexibility and range of motion, promotes new blood vessel growth, accelerates wound healing, may have cardioprotective effects.
Potential Side Effects
Generally well-tolerated. Some users report headache, nausea, lightheadedness, or fatigue. Injection site irritation is possible. Long-term safety in humans requires further study.
Find TB-500 Providers Near You
Browse 35 providers offering TB-500 therapy in our directory.
Browse ProvidersFrequently Asked Questions
Promotes tissue repair and regeneration, reduces inflammation and scar tissue formation, increases flexibility and range of motion, promotes new blood vessel growth, accelerates wound healing, may have cardioprotective effects.
TB-500 therapy typically costs between $120 and $280 per month, though prices vary by provider, location, and dosage.
TB-500 has an FDA status of "Research". It is currently used in research and clinical settings. Consult with a qualified provider about its regulatory status and appropriate use.
Generally well-tolerated. Some users report headache, nausea, lightheadedness, or fatigue. Injection site irritation is possible. Long-term safety in humans requires further study.
PeptideProbe lists 35 providers offering TB-500 therapy. Use our directory to search by location, filter by telehealth availability, and compare providers.
Related Peptides
Medical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.